We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
-18.82%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.03B
AUM Growth
-$200M
Cap. Flow
+$16M
Cap. Flow %
1.55%
Top 10 Hldgs %
58.26%
Holding
811
New
317
Increased
98
Reduced
90
Closed
269

Top Buys

Rank Stock Value
1
VAL icon
Valaris
VAL
+$24.3M
2
MRNA icon
Moderna
MRNA
+$9.63M
3
SLV icon
iShares Silver Trust
SLV
+$9.23M
4
TMUS icon
T-Mobile US
TMUS
+$9.02M
5
NE icon
Noble Corp
NE
+$6.74M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$107M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$29M
3
APTV icon
Aptiv
APTV
+$22.6M
4
MSFT icon
Microsoft
MSFT
+$20.8M
5
AMZN icon
Amazon
AMZN
+$12.7M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Consumer Discretionary 12.31%
3 Materials 12.15%
4 Industrials 5.19%
5 Financials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRSN
451
DELISTED
Mersana Therapeutics
MRSN
$221K 0.02%
+1,917
New +$180K
EFX icon
452
Equifax
EFX
$21.4B
$218K 0.02%
+1,193
New +$239K
TW icon
453
Tradeweb Markets
TW
$22B
$218K 0.02%
+3,190
New +$232K
MC icon
454
Moelis & Co
MC
$4.77B
$217K 0.02%
5,523
-17,070
-76% -$745K
STRO icon
455
Sutro Biopharma
STRO
$424M
$216K 0.02%
+4,154
New +$232K
GLD icon
456
SPDR Gold Trust
GLD
$142B
$211K 0.02%
1,250
-11,750
-90% -$2.05M
DCT
457
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
$211K 0.02%
+14,217
New +$250K
X
458
DELISTED
US Steel
X
$210K 0.02%
+11,749
New +$321K
CHRW icon
459
C.H. Robinson
CHRW
$17.4B
$209K 0.02%
+2,064
New +$215K
BMI icon
460
Badger Meter
BMI
$3.98B
$208K 0.02%
+2,572
New +$213K
APA icon
461
APA Corp
APA
$14.1B
$205K 0.02%
+5,886
New +$250K
APAM icon
462
Artisan Partners
APAM
$3.02B
$205K 0.02%
5,762
-8,935
-61% -$325K
ESE icon
463
ESCO Technologies
ESE
$7.88B
$204K 0.02%
2,982
-4,422
-60% -$289K
ZEUS
464
DELISTED
Olympic Steel
ZEUS
$204K 0.02%
+7,934
New +$267K
EDIT icon
465
Editas Medicine
EDIT
$438M
$202K 0.02%
+17,101
New +$229K
VOXX
466
DELISTED
VOXX International Corporation Class A
VOXX
$202K 0.02%
21,749
+3,074
+16% +$25.3K
NXDT
467
NexPoint Diversified Real Estate Trust
NXDT
$237M
$198K 0.02%
+12,000
New +$186K
EVC icon
468
Entravision Communication
EVC
$1.04B
$197K 0.02%
43,191
EPM icon
469
Evolution Petroleum
EPM
$133M
$196K 0.02%
35,957
-11,911
-25% -$80.1K
PAGS icon
470
PagSeguro Digital
PAGS
$2.55B
$193K 0.02%
+18,811
New +$270K
SILJ icon
471
Amplify Junior Silver Miners ETF
SILJ
$3.9B
$190K 0.02%
+20,000
New +$239K
NVGS icon
472
Navigator Holdings
NVGS
$1.27B
$186K 0.02%
+16,495
New +$213K
TG icon
473
Tredegar Corp
TG
$290M
$185K 0.02%
18,520
-27,798
-60% -$323K
UONEK icon
474
Urban One Class D
UONEK
$23.9M
$185K 0.02%
4,318
-1,377
-24% -$80.2K
TBCH
475
Turtle Beach Corp
TBCH
$256M
$183K 0.02%
+14,958
New +$255K

Similar funds

Caxton Associates (New York)'s Q2 2022 Portfolio in Review

As of Q2 2022, Caxton Associates (New York) held 811 positions worth $1.03B, down 16% from $1.23B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Caxton Associates (New York)'s Q2 2022 filing shows 317 new, 98 increased, 90 reduced and 269 closed positions. Its largest new stake was Valaris: 451,426 shares worth $19.1M. The largest sale was Tesla, an estimated $107M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Caxton Associates (New York)'s largest Q2 2022 buy was Valaris: 451,426 shares worth $19.1M.
  • Caxton Associates (New York) added most to Moderna in Q2 2022, an estimated $9.63M increase.
  • Caxton Associates (New York)'s biggest Q2 2022 reduction was Aptiv, cutting an estimated $22.6M.
  • Caxton Associates (New York) fully exited Tesla in Q2 2022, selling an estimated $107M.
  • Caxton Associates (New York)'s ten largest holdings make up 58% of its $1.03B portfolio in Q2 2022.
  • Caxton Associates (New York) opened 317 new positions and closed 269 in Q2 2022.
  • Caxton Associates (New York)'s portfolio value fell 16% quarter-over-quarter to $1.03B.

Based on Caxton Associates (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.